ArticleScientific reports2017

A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines.

Neal Van Hoeven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.